Antiglaucoma medications: Nursing pharmacology

Last updated: February 22, 2026

Antiglaucoma medications: Nursing pharmacology

gap test med surg

gap test med surg

Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology

Notes

ANTIGLAUCOMA MEDICATIONS, PART 1
DRUG NAME
timolol (Istalol, Betimol); levobunolol; betaxolol (Betoptic-S)
brinzolamide (Azopt); acetazolamide
latanoprost (Xalatan, Xelpros); bimatoprost (Lumigan)
CLASS
Beta-adrenergic blockers
Carbonic anhydrase inhibitors
Prostaglandin analogs
MECHANISM OF ACTION
Decreased aqueous humor production
Increased aqueous humor outflow
INDICATIONS
  • Treatment of chronic open-angle and closed-angle glaucoma
  • Initial treatment of acute closed-angle glaucoma
ROUTE(S) OF ADMINISTRATION
  • TOP
  • brinzolamide - TOP
  • acetazolamide - PO,  IV
  • TOP
SIDE EFFECTS
  • Common side effects: blurred vision, stinging, eye redness, and itching after topical use
  • Hypotension
  • Decreased cardiac output
  • Bradycardia
  • Shortness of breath
  • Boxed warning: Stevens-Johnson syndrome and blood dyscrasias
  • Paresthesias
  • Upset stomach
  • Metabolic acidosis
  • Frequent urination
  • Darkening of iris and eyelids
  • Eyelash growth
  • Droopy eyelids
  • Sunken eyes
CONTRAINDICATIONS AND CAUTIONS
  • AV block
  • Decompensated heart failure
  • Bradycardia
  • Asthma
  • Sickle cell anemia
  • Renal failure
  • Addison disease
-
ANTIGLAUCOMA MEDICATIONS, PART 2
DRUG NAME
pilocarpine (Isopto Carpine)
brimonidine (Alphagan P); apraclonidine (Iopidine)
mannitol (Osmitrol)
CLASS
Cholinergic agents
Alpha-adrenergic agonists
Hyperosmotic agents
MECHANISM OF ACTION
Increased aqueous humor outflow
Decreased aqueous humor production

Increased aqueous outflow
Osmotic gradient dehydrates vitreous humor, thus lowering intraocular pressure
INDICATIONS
  • Treatment of chronic open-angle and closed-angle glaucoma
  • Initial treatment of acute closed-angle glaucoma
ROUTE(S) OF ADMINISTRATION
  • TOP
  • TOP

  • Mannitol - IV

SIDE EFFECTS
  • Common side effects: blurred vision, stinging, eye redness, and itching after topical use
  • Miosis, increased lacrimation, decreased night vision
  • Sweating, drooling, GI problems
  • Headache
  • Drowsiness
  • Dry mouth / nose
  • Nausea and vomiting
  • Frequent urination
  • Cardiovascular overload
  • Fever
  • Pulmonary edema
CONTRAINDICATIONS AND CAUTIONS
-
  • AV block
  • Decompensated heart failure
  • Bradycardia
  • Severe dehydration
  • Renal failure
  • Cardiac diseases
NURSING CONSIDERATIONS: ANTIGLAUCOMA MEDICATIONS
ASSESSMENT AND MONITORING
Assessment
  • Current symptoms of glaucoma
  • Laboratory test results:  CBC, renal and hepatic function, electrolytes
  • Diagnostic test results: visual acuity, intraocular pressure

Monitoring
  • Development of side effects, resolution of glaucoma symptoms
  • Evaluate for decreased intraocular pressure
CLIENT EDUCATION
  • Purpose of medication: to help reduce the pressure in their eyes, preventing loss of vision caused by glaucoma
  • Correct technique for self-administration
  • Side effects
  • Take medication exactly as prescribed
  • Caution against stopping the medication abruptly
  • Keep their regularly scheduled appointments to monitor their intraocular pressure
  • Timolol
    • Instill one drop in each affected eye as directed; either once daily in the morning or twice daily, depending on the solution
    • Symptoms of systemic absorption: bronchoconstriction, hypotension, bradycardia
      • Contact healthcare provider
  • Latanoprost
    • Instill one drop in each affected eye once daily in the evening
    • Side effects: heightened brown pigmentation of iris; increased eyelid pigmentation; length, thickness and coloration of eyelashes
    • Dry eye
      • Contact their healthcare provider for advice
Author: Anna Hernández, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antiglaucoma medications are used to treat glaucoma, which refers to a group of eye conditions in which drainage of aqueous humor out of the eye is restricted, causing an increased intraocular pressure.

Now, antiglaucoma medications can be divided based on their mechanism of action into two classes: those that decrease aqueous humor production, and those that increase aqueous outflow.

Medications to decrease aqueous humor production include beta-adrenergic blockers, like timolol, levobunolol, and betaxolol; and carbonic anhydrase inhibitors, like brinzolamide and acetazolamide.

On the other hand, medications to improve aqueous outflow include prostaglandin analogs, like latanoprost and bimatoprost; and cholinergic agents, like pilocarpine.

Additionally, some medications can work by both decreasing the production and increasing the outflow of aqueous humor, including alpha-adrenergic agonists like brimonidine and apraclonidine. Finally, acute cases can be treated with osmotic diuretics, like mannitol.

After administration, osmotic diuretics act as hyperosmotic agents by creating an osmotic gradient that attracts water out of the eyes and into the blood, to rapidly decrease intraocular pressure.

Almost all medications are administered as eye drops, with the exception of acetazolamide and mannitol, which can be administered orally and intravenously.

Alright, now the most common side effects of antiglaucoma eye drops include blurred vision, eye redness, stinging, and itching following application.

In particular, beta-adrenergic blockers cause neurological side effects like headache, depression, hallucination, and sleep problems, like insomnia and nightmares.

Other side effects include hypotension, decreased cardiac output, and bradycardia, as well as bronchospasm leading to cough or dyspnea.

On the other hand, carbonic anhydrase inhibitors may cause neurologic side effects, such as dizziness, drowsiness, and fatigue.

Carbonic anhydrase inhibitors can also cause gastrointestinal side effects, such as nausea, vomiting, and diarrhea or constipation.

Now, acetazolamide in particular can also often cause electrolyte abnormalities, such as hypokalemia and hyperchloremia; as well as altered blood glucose levels, which can lead to hypo- or hyperglycemia.

This can manifest as neurological side effects like headache, seizures, mental status changes, and paresthesia.

Finally, acetazolamide can cause serious side effects like hepatotoxicity, and has a boxed warning for blood dyscrasias, like pancytopenia, as well as for hypersensitivity reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis.

On the other hand, prostaglandin analogs are most often associated with side effects involving the eye itself, including darkening of the iris and eyelids, as well as eyelash growth.

Cholinergic agents can cause miosis, increased lacrimation, and decreased night vision. Systemic side effects may include sweating, drooling, and gastrointestinal problems, among others.

Alpha-adrenergic agonists may cause side effects like eye burning and tearing, photophobia, and blurred vision. In addition, some clients may experience headache, dizziness, and somnolence, as well as dry nose or mouth, coughing, and dyspnea.

Finally, the most common side effect of osmotic diuretics is frequent urination. In addition, these medications can also pull water from cells into the extracellular space, which could worsen edematous conditions like heart failure and pulmonary edema.

As more water gets pulled into the blood vessels, the concentration of sodium will go down, causing dilutional hyponatremia. Other side effects include dehydration, hypotension, confusion, headache, nausea, and vomiting, which occur due to the rapid fluid shift.

Now, antiglaucoma medications should be used with caution during pregnancy and breastfeeding, while contraindications depend on the specific medication.

Beta-adrenergic blockers and alpha-adrenergic agonists should be avoided in clients with cardiovascular conditions like hypotension, severe bradycardia, second or third degree atrioventricular block, and decompensated heart failure.

In addition, beta-blockers should be used with caution in clients with respiratory disorders, such as asthma and chronic obstructive pulmonary disease or COPD; as well as in those with diabetes mellitus.

On the other hand, alpha-adrenergic agonists should be used with caution in clients with cerebrovascular disease or Raynaud phenomenon.

Next, carbonic anhydrase inhibitors are contraindicated in clients with severe renal or hepatic disease, severe renal or hepatic failure, sickle cell anemia, or Addison’s disease; and should be used with caution in clients with COPD.

Finally, osmotic diuretics are contraindicated in clients with severe hypovolemia or dehydration, severe renal impairment and anuria; and should be used with caution in clients with edematous conditions, such as heart failure and pulmonary edema.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition" McGraw Hill / Medical (2022)
  6. "New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost" Eye (Lond) (2020)
  7. "Changes in Corneal Epithelial Thickness Induced by Topical Antiglaucoma Medications" Journal of Clinical Medicine (2021)
  8. "Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface" Niger Med J (2020)